How Kishore Biyani's maverick moves pushed him to breaking point
The pioneer of India’s modern retail built an empire but created little value for shareholders
Krishna Gopalan - July 10, 2020
While jumping off a cliff or a helicopter, Rajiv Bhalla slows down and appreciates life
Barco India MD is always seeking discomfort through different adventure sports
Shailaja Mohapatra - July 24, 2020
Will Glenmark’s COVID-19 drug give it a new lease of life or just a short energy boost?
The pharma major has taken a different path from peers, in launching a new drug instead of inking a licensing deal
Shruti Venkatesh - July 04, 2020
The Chinese spell
The apps making your life easier are backed by the country that you are trying to boycott
June 27, 2020
Is Godrej Agrovet a ‘value buy’ post the steep correction in its stock price?
A strong parentage, healthy balance sheet and focused management is helping the company brave the COVID-19 disruption
Anishaa Kumar - June 02, 2020
What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
RP Singh's adventures in the wild
Nucleus Software CEO does not let a call of the wild go to waste; he captures every moment in his frame
Rishabh Bhatnagar - April 29, 2020
The sneeze that shook the world, and India. How bad is bad?
Having squeezed their cash flow, the COVID-19 pandemic is draining the lifeblood out of companies, big and small
V Keshavdev - April 11, 2020
How global markets reacted during recent pandemics
A Covid-induced recession globally and a faltering economy back home could well mean that a secular revival in equities is out of question
Shruti Venkatesh - March 24, 2020
JLL India CEO and country head sneaks time out of his busy schedule to catch up on his reading or stay updated on tennis and cricket games
March 11, 2020